about
Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.The skin aging exposomeCompounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor ResistanceTreatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response.[Pigmentary lasers].Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.The new 940-nanometer diode laser: an effective treatment for leg venulectasia.[The 308 nm excimer laser in dermatology].Melanin pigmentary disorders: treatment update.Use of the 308-nm excimer laser for psoriasis and vitiligo.Comparative treatment of extragenital lichen sclerosus with methylaminolevulinic Acid pulsed dye laser-mediated photodynamic therapy or pulsed dye laser alone.308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study.[What is the impact of the new clinical trial data? What are the lessons for patient management?].Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.Pigmentary sequelae of AIDS-related cutaneous Kaposi sarcoma: successful treatment by Q-switched 755-nm alexandrite and 532-nm Nd:YAG lasers.Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skinCyclic AMP promotes a peripheral distribution of melanosomes and stimulates melanophilin/Slac2-a and actin association.Laser-assisted depigmentation for resistant vitiligo: a retrospective case series with long-term follow-up.[Lasers].AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanomaTreatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial.Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases.Copper Bromide Laser vs Triple-Combination Cream for the Treatment of Melasma: A Randomized Clinical Trial.Endothelial Cells Promote Pigmentation through Endothelin Receptor B Activation.SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentationPrognosis and response to laser treatment of early-onset hypertrophic port-wine stains (PWS).Fractionated bipolar radiofrequency and bipolar radiofrequency potentiated by infrared light for treating striae: A prospective randomized, comparative trial with objective evaluation.Genetic disorders of pigmentation.Physiopathology and genetics of vitiligo.What's new in hypochromy.Regulation of human skin pigmentation and responses to ultraviolet radiation.Immunohistochemistry and in situ hybridization in the study of human skin melanocytes.Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1rForskolin protects keratinocytes from UVB-induced apoptosis and increases DNA repair independent of its effects on melanogenesis.Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acidWhat are melanocytes really doing all day long...?Melasma pathogenesis and influencing factors - an overview of the latest research.Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata.Comparison of two picosecond lasers to a nanosecond laser for treating tattoos: a prospective randomized study on 49 patients.
P50
Q27852303-DDFB805F-37F9-4727-8650-F0FB15BDA2F9Q28069351-A952DB4C-1CC0-45AE-8953-A169A7483A0DQ28115258-793D33BC-1AAD-46F2-A491-278EEC630A25Q30837806-831556DE-F32E-4D5C-AC97-486147090DDAQ30909698-77BFF4B8-2BD2-4014-B9B0-5D9E61512695Q31114137-70734483-8825-4C66-8473-A40795667092Q31141461-52C5A9EC-69CD-4C4F-B6EC-59D09AFA01DFQ31157352-100D508E-3E3B-4A4F-AD64-CF1A4A1C35E7Q31160867-F1EF5417-2E4E-42BD-ACFD-3B1C18CFC442Q33232201-545628DE-30EA-4718-8542-D2CFFB9146D1Q33434118-8929ADB5-76A0-410D-81C6-4C51DB5425A2Q33546636-7AC1BA6C-D176-407B-9A30-E5F0E13796E4Q33590255-5BB127FE-B6DB-4BC2-8AF3-A49629FB492EQ33891014-81C7AD9D-DAF2-4184-96C0-5F29732AE758Q33964853-AAB04A27-4646-4478-9916-7EFF6DFC488CQ33985283-2FFDCDBC-E4FA-4DE4-B84F-7EB2FA4F7E8CQ34146062-5DB66E32-8222-4535-B021-1C4B487A419FQ34310475-3804CEBE-7EBF-45A9-B36F-DA81B369F1AFQ34483418-4B46C27B-C61B-453E-9476-587232F7E13AQ34520454-39048A45-ACB8-41A4-A5D1-9806397C182CQ34836194-C36037B0-EE60-44F2-882B-692C843ADA4AQ35123506-E5CD5525-7F2A-47B5-A182-D16C0C52C9B4Q35485972-7B911C0A-96E3-4F6B-B870-CB35C52D6655Q35567717-915646E8-D3DE-4F9A-8301-B93823F33AE0Q35755885-CBA1354B-983C-4FDD-87DF-43C2D9A0A774Q35956740-868EDE88-6BD2-46B8-91B3-FB2C27C55651Q35966700-EA3B4B35-8ABD-444F-B4BA-EF437B12A04CQ35971777-420AE8DE-F5DF-4E6B-8167-89308DB4B2D7Q36039702-F4BF9791-09B6-4845-BCF3-3D2297B70E52Q36317865-66CDEE92-4ED9-4ED2-830C-AE7F8E1BD1A5Q36502877-DC1EE0ED-090C-4102-B01E-073796EA8C56Q36717406-A26A326C-A861-4F65-9426-2BEA45FBAAE3Q36730790-5DF2137D-6A62-4C1C-B1F8-12D6ABC64525Q37100856-83E3E105-9075-4D25-9697-717A27A42080Q37125731-27DEA8D7-E006-496F-848D-E29DAD887E23Q37143334-CB91E331-3F57-459C-BB1F-9419E826E283Q37472801-EF56575E-0222-427B-B638-6D2C95D86FFEQ38064487-42A8D6C3-CB1F-4D15-BE8B-149EBFDE0221Q38429515-5EE06845-D0D2-425F-9C4A-FA247B099DA0Q38652438-E43F22A5-721E-49D5-BFE6-4A8AC5E5FB57
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Thierry Passeron
@ast
Thierry Passeron
@en
Thierry Passeron
@es
Thierry Passeron
@nl
Thierry Passeron
@sl
type
label
Thierry Passeron
@ast
Thierry Passeron
@en
Thierry Passeron
@es
Thierry Passeron
@nl
Thierry Passeron
@sl
prefLabel
Thierry Passeron
@ast
Thierry Passeron
@en
Thierry Passeron
@es
Thierry Passeron
@nl
Thierry Passeron
@sl
P214
P106
P1153
7004178755
P21
P214
P31
P496
0000-0002-0797-6570
P735
P7859
lccn-n2016187923